>General Information


Sponsored by:

Biomarker Research Program



All times are Pacific Standard Time (PST)

>Download Symposium Brochure

8:00-8:10 AM
Introductions, Welcome and Program Overview
Drs. Alan Maisel and Lori Daniels

SESSION I: Acute Coronary Syndrome
Allan Jaffe, Moderator

8:10 – 8:30AM
hsTn in the Evaluation of Patients
Frank Peacock, MD

8:30 – 9:00AM
State of the Art Talk: Point of Care Troponin
Pedro Lopez Ayala, MD, MSc

9:00 – 9:20AM
Biomarkers and Type 1 vs Type 2 MI
Hanna Gaggin, MD

9:20 – 9:50AM
Acute Coronary Syndrome Case Presentations/Panel
Drs. Lopez Ayala, Gaggin, Jaffe, Peacock, Daniels

9:50 – 10:15AM    Break/Visit Exhibits

SESSION II: Biomarkers in Heart Failure
Alan Maisel, MD Moderator

10:15 – 10:30AM
Biomarkers for Predicting, Managing and Guiding CVD
Lori Daniels, MD

10:30 – 10:45AM
HFpEF Biomarkers
Rudolf deBoer, MD

10:45 – 11:00AM
Recent Therapies in Heart Failure (Entresto, ivabradine, CCM, etc)
Eric Adler, MD

11:00 – 11:15AM
Cardiologists and HbA1c: Novel Diabetes Drugs and the Cardiologist as Diabetician
Gregg Fonarow, MD

11:15 – 11:30AM
Amyloid Cardiomyopathy: New Opportunities
Tony Urey, MD

11:30 – 12:00PM
Heart Failure Case Presentations and Panel
Drs. Maisel, Fonarow, Adler, Urey, deBoer, Wettersten, Daniels

12:00 – 1:00
Product Theatre
The Next Horizon in the Heart Failure Treatment Paradigm for Patients With HFrEF
Warren Fegenbush, PharmD, BCPS

SESSION III: Devices, COVID-19 and Personalized Medicine
Lori Daniels, MD, Moderator

1:05 – 1:20PM
Wearable Devices and Apps for Heart Disease and Health
Jia Shen, MD

1:20 – 1:35PM
Machine Learning and Biomarkers: A marriage made in heaven
Alan Maisel, MD

1:35 – 2:05PM
COVID-19 as a disease of the Endothelium
Tom Lόscher, MD

2:05 – 2:35PM
COVID-19 and Biomarkers for Prognosis and Guiding Treatment?
Torbjorn Omland, MD

2:35 – 2:55PM
Lipid Biomarkers and Therapies
Pam Taub, MD

2:55 – 3:20PM    Break/Visit Exhibits

SESSION IV: Biomarkers in Arrhythmias and Pulmonary Arterial Hypertension, and Devices
Alan Maisel, Moderator

3:20 – 3:35PM
International Normalized Ratio (INR) as a Biomarker – Anticoagulation and Reversal in AFib, Heart Failure and Cardiovascular Disease
Daniel Blanchard, MD

3:35 – 3:50PM
INR as a Biomarker – Part 2: Left Atrial Appendage Occlusion Devices for Doing Away with INR
Ryan Reeves, MD

3:50 – 4:05PM
Biomarkers and Arrhythmias/Devices
David Krummen, MD

4:05 – 4:20PM
Cardiomems: Incorporating a Pulmonary Artery Device and Biomarkers in Outpatients with Heart Failure
Howie Tran, MD

4:20 – 4:35PM
Biomarkers and Treatment in Pulmonary Arterial Hypertension
Tim Fernandes, MD

4:35 – 4:50PM
Potassium as a Treatable Biomarker in Cardiovascular Disease:
New Keys to Hyperkalemia
Nicholas Wettersten, MD

4:50 – 4:55PM
Concluding Remarks
Drs. Alan Maisel and Lori Daniels